Wednesday, Church & Dwight Co., Inc. (CHD) said the U.S. Food and Drug Administration has approved its FIRST RESPONSE Early Result Pregnancy Test, which is based on patent-pending Polymeric Amplification Technology that can detect the pregnancy hormone at lower levels than existing tests in the market.
The FIRST RESPONSE test can detect pregnancy hormone human chorionic gonadotropin, commonly known as hCG, up to six days before the day of a woman's missed period, the company said. The company also claimed that it can detect pregnancy one day before any other at-home pregnancy test available in the market.
FIRST RESPONSE pregnancy kits work by detecting the presence of hCG in a woman's urine. Polymeric Amplification Technology increases the overall sensitivity of the testing device, resulting in better detection of the pregnancy hormone. HCG begins to appear in a pregnant woman 8-10 days after fertilization. The amount of hCG doubles every 36-48 hours as the pregnancy progresses.
Mary Jane Minkin, clinical professor of Obstetrics and Gynecology at Yale University School of Medicine, said, "A pregnancy test with results this early sets the stage for a healthy baby and a healthy mother. This latest advancement means pregnant women can initiate a healthier lifestyle even sooner in the critical first stages of a baby's development. Women who want results quickly will undoubtedly have less anxiety when taking this at-home test."
CHD is losing $0.22 or 0.36%, and is trading at $60.73 on a volume of 84 thousand shares on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.